FB Nasdaq FB Facebook

Pre-Market Movers: Exxon Mobil Corporation(NYSE:XOM), Advaxis, Inc.(NASDAQ:ADXS), Inteliquent Inc(NASDAQ:IQNT)

Exxon Mobil Corporation(NYSE:XOM) gained in early trading after reporting earnings that beat Wall Street estimates. The energy producer estimated that Q1 EPS declined 1% from a year earlier to $2.10, beating the consensus forecast of $1.88 measured by Capital IQ. Revenue fell 1% from the prior year to $106.8 billion, missing the analyst forecast of $111 billion. ExxonMobil rose 0.3% to $102.73 in early trading. … Continue reading Pre-Market Movers: Exxon Mobil Corporation(NYSE:XOM), Advaxis, Inc.(NASDAQ:ADXS), Inteliquent Inc(NASDAQ:IQNT)

St. Jude Announces Consistent Q3 Results

St. Jude Medical released third-quarter performance that was generally consistent with our expectations, and we have not altered our projections for the full year.  However, we plan to modestly raise our fair value estimate to reflect the reduced share count and cash flow realized since our last update. While St. Jude continues to wrestle with a lackluster implantable cardioverter defibrillator market, we still think the … Continue reading St. Jude Announces Consistent Q3 Results

ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

ATMI reported third-quarter results that were slightly below our expectations due to near-term softness in manufacturing activity in the chip industry. We are maintaining our fair value estimate and moat rating. For the quarter, revenue was $100.2 million, down 2% sequentially and down from sales of $109 million in the year-ago quarter. A near-term slowdown in semiconductor industry manufacturing activity affected demand for ATMI’s products, … Continue reading ATMI Posts Disappointing Earnings; Revenue Drops to $100.2 Million

Sonoco Results Driven by Higher Pricing and Demand

Sonoco Products announced solid third-quarter results on Thursday, driven primarily by higher overall pricing and improving demand in the Paper & Industrial Converted Products and Display Packaging segments. Management increased its full-year free cash flow (excluding dividend payments of about $129 million) target to $190 million from $150 million and tightened full-year guidance to $2.27-$2.32 per share from $2.26-$2.32 per share; we expect to leave … Continue reading Sonoco Results Driven by Higher Pricing and Demand

Roche’s Top-line Results on Track to Meet Guidance

Roche reported top-line results for the third quarter that put it on track to meet our expectations for the full year. Roche’s oncology drug portfolio and diagnostics segment form the basis of its personalized medicine strategy, feeding into the firm’s strong intangible assets and wide economic moat. At constant currencies, Roche’s sales were up 8% in the third quarter, with 9% pharmaceutical growth and 7% … Continue reading Roche’s Top-line Results on Track to Meet Guidance

BBVA Cuts Stake to 9.9% in CITIC Bank

Banco Bilbao Vizcaya Argentaria announced that it is reducing its 15% stake in China CITIC Bank to 9.9% in order to increase its Basel III capital ratio. Because it will be below 10%, the CITIC stake will no longer be considered a “significant” investment, which alters the accounting methodology. The accounting will change from the equity method to available for sale, which requires marking to market. … Continue reading BBVA Cuts Stake to 9.9% in CITIC Bank